Ansbert Gadicke's Net Worth
Ansbert Gadicke's net worth is estimated to be at least $11,586,830.64 as of 11/08/2024. CoreStreet's estimation of Ansbert Gadicke's net worth is based on their sale of stock and current holding of stock.
Ansbert Gadicke is Major Shareholder at Iteos Therapeutics Inc. They have executed at least 31 trades of stock as per SEC Form 4 filings. Their most recent trade was for 60,808 units of ITOS stock on 11/24/2021. Their biggest sale was on 11/24/2021 when they sold 60,808 units of Iteos Therapeutics Inc stock for $2,206,722.32. They typically trade 31 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $11,586,830.64
Most recent insider trade:
- Nov. 24, 2021
Ansbert Gadicke's Insider Trading History
| Iteos Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 24, 2021 | Major Shareholder | 60,808 | $36.29 | Sell | $2,206,722.32 |
Nov. 22, 2021 | Major Shareholder | 35,333 | $37.52 | Sell | $1,325,694.16 |
Sept. 13, 2021 | Major Shareholder | 35,785 | $27.64 | Sell | $989,097.40 |
Sept. 9, 2021 | Major Shareholder | 38,028 | $28.97 | Sell | $1,101,671.16 |
Sept. 7, 2021 | Major Shareholder | 50,996 | $29.18 | Sell | $1,488,063.28 |
| Cullinan Oncology LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 15, 2021 | Director | 888 | $29.16 | Sell | $25,894.08 |
Sept. 13, 2021 | Director | 497 | $29.10 | Sell | $14,462.70 |
Sept. 9, 2021 | Director | 1,898 | $29.35 | Sell | $55,706.30 |
Sept. 7, 2021 | Director | 3,465 | $29.04 | Sell | $100,623.60 |
Sept. 3, 2021 | Director | 1,760 | $29.60 | Sell | $52,096.00 |
Sept. 1, 2021 | Director | 790 | $29.47 | Sell | $23,281.30 |
Aug. 30, 2021 | Director | 4,285 | $29.30 | Sell | $125,550.50 |
Aug. 27, 2021 | Director | 1,846 | $29.09 | Sell | $53,700.14 |
Aug. 25, 2021 | Director | 237 | $29.09 | Sell | $6,894.33 |
Aug. 23, 2021 | Director | 7,376 | $29.11 | Sell | $214,715.36 |
Aug. 11, 2021 | Director | 347 | $29.05 | Sell | $10,080.35 |
| Harpoon Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 1, 2021 | Major Shareholder | 18,491 | $20.44 | Sell | $377,956.04 |
May 28, 2021 | Major Shareholder | 13,885 | $21.12 | Sell | $293,251.20 |
May 26, 2021 | Major Shareholder | 3,198 | $20.04 | Sell | $64,087.92 |
May 24, 2021 | Major Shareholder | 5,000 | $20.12 | Sell | $100,600.00 |
May 21, 2021 | Major Shareholder | 10,907 | $20.21 | Sell | $220,430.47 |
May 19, 2021 | Major Shareholder | 17,833 | $20.39 | Sell | $363,614.87 |
May 17, 2021 | Major Shareholder | 4,666 | $20.07 | Sell | $93,646.62 |
May 14, 2021 | Major Shareholder | 6,900 | $20.04 | Sell | $138,276.00 |
May 12, 2021 | Major Shareholder | 29,684 | $20.53 | Sell | $609,412.52 |
May 10, 2021 | Major Shareholder | 17,133 | $21.80 | Sell | $373,499.40 |
April 21, 2021 | Major Shareholder | 8,972 | $18.97 | Sell | $170,198.84 |
April 19, 2021 | Major Shareholder | 10,056 | $19.30 | Sell | $194,080.80 |
April 16, 2021 | Major Shareholder | 5,847 | $19.86 | Sell | $116,121.42 |
April 12, 2021 | Major Shareholder | 20,628 | $21.02 | Sell | $433,600.56 |
April 9, 2021 | Major Shareholder | 10,300 | $23.67 | Sell | $243,801.00 |